Disposition of 56361 shares by Junyuan Wang of Nuvation Bio at 2.89 subject to Rule 16b-3

NUVB Stock  USD 2.05  0.03  1.44%   
About 62% of Nuvation Bio's investor base is looking to short. The analysis of the overall investor sentiment regarding Nuvation Bio suggests that many traders are alarmed. The current market sentiment, together with Nuvation Bio's historical and current headlines, can help investors time the market. In addition, many technical investors use Nuvation Bio stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Nuvation Bio Director, Officer: Ceo, Anheart Therapeutics Ltd.. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Read at macroaxis.com
Disposition of 56361 class a common stock at 2.89 of Nuvation Bio by Junyuan Wang on 11th of November 2024. This event was filed by Nuvation Bio with SEC on 2024-11-11. Statement of changes in beneficial ownership - SEC Form 4

Nuvation Bio Fundamental Analysis

We analyze Nuvation Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nuvation Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nuvation Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Gross Profit

Gross Profit Comparative Analysis

Nuvation Bio is currently under evaluation in gross profit category among its peers. Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.

Nuvation Bio Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Nuvation Bio stock to make a market-neutral strategy. Peer analysis of Nuvation Bio could also be used in its relative valuation, which is a method of valuing Nuvation Bio by comparing valuation metrics with similar companies.

Complementary Tools for Nuvation Stock analysis

When running Nuvation Bio's price analysis, check to measure Nuvation Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nuvation Bio is operating at the current time. Most of Nuvation Bio's value examination focuses on studying past and present price action to predict the probability of Nuvation Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nuvation Bio's price. Additionally, you may evaluate how the addition of Nuvation Bio to your portfolios can decrease your overall portfolio volatility.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
CEOs Directory
Screen CEOs from public companies around the world
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios